Discovery of new biomarker could provide personalized treatment options for bladder cancer

(The Mount Sinai Hospital / Mount Sinai School of Medicine) A research team at Mount Sinai has identified two microRNA activity-based biomarkers that can provide insights regarding which patients with p53-like bladder cancer may have a better versus worse prognosis.